Abstract:OBJECTIVE To explore the role of losartan and carvedilol on extracellular signal-regulated kinase (ERK) and mitogen-actirated protein kinase phosphatase-1 (MKP-1) in the myocardium of spontaneously hypertensive rat (SHR). METHODS Twenty-one 14-week old SHRs were randomily divided into 3 groups, 7 rats each. One group was given with carvedilol 30 mg·kg~(-1)·d~(-1), one group was given with losartan 10 mg·kg~(-1)·d~(-1) for 8 weeks, while the SHR sham group and 7 Wistar Kyoto rats(WKY)as control group were routinely given with vehicle (0.5% carboxymethyl cellulose) only for equal time. Then the activity of ERK and the expression of MKP-1 mRNA in myocardium were studied by immuno-precipitation and RT-PCR, respectively. RESULTS ①After administration for 8 weeks, the blood pressure of the SHR group treated with carvedilol or losartan decreased significantly (P0.01). LVW/BW ratio in SHR with carvedilol or losatan treatment was lower than that in SHR sham group (carvedilol group, P0.01, losartan group, P0.05), and the reduction in hypertrophy with losartan treatment was more than with carvedilol (P0.05). ②After treatment in SHR, the activity of ERK in the group with carvedilol or losartan can treatment was lower than that in the SHR control (P0.01), while the expression of MKP-1 mRNA of them was higher (P0.05). CONCLUSION Both carvedilol and losartan can inhibit the activity of ERK, increase the expression of MKP-1 mRNA, and then relieve cardiacl hypertrophy.

Role of Losartan and Carvedilol on in Extracellular Signal-Regulated Kinases in Myocardium of Spontaneously Hypertensive Rats